Answers are grounded in this paper and cite their sources.
Introduction and objectives: To explore if the clinical neurological damage that hyperglycemia could produce may be attenuated by elevated levels of serum uric acid (SUA).Methods: Prospective registry that included patients with acute ischemic stroke admitted within 24 h after the event.We divided them into three groups according to their levels of fasting blood glucose (FBG) (FBG < 140 mg/dL, FBG 140-180 mg/dL, and FBG ≥ 180 mg/dL) and subdivided them according to SUA levels (> 6 mg/dL in women and > 7 mg/dL in men).We assessed the worsening of both neurological (based on National Institute of Health Stroke Scale [NIHSS]) and functional damage based on Rankin scale.Results: We analyzed 504 patients (53.9% men).Type 2 diabetes mellitus was present in 163 (32.4%) patients and hyperuricemia in 118 (23.4%).The persons belonging to the FBG groups were increasing their neurological (NIHSS) and functional (Rankin) punctuation when their glucose levels raised (p = 0.07).Overall, the groups with hyperuricemia had lower but not significant scores in stroke severity (NIHSS) comparing to the groups without hyperuricemia (p = 0.1).In the logistic regression model, the odds ratio to have a NIHSS score higher than 16 increased as glucose levels were higher and again decreased in the groups with hyperuricemia without reach statistical significance.Conclusion: In patients with acute ischemic stroke with hyperglycemia, we found a non-significant tendency between SUA and lower clinical neurological damage.Further studies with larger samples and prospective follow-up are needed to confirm this potential protective role.
No takes yet. Share an insight, caveat, or question.
Arévalo‐Lorido et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: